Literature DB >> 23010327

Biochemical and structural characterization of recombinant human serum transferrin from rice (Oryza sativa L.).

Ashley N Steere1, Cedric E Bobst, Deshui Zhang, Steve C Pettit, Igor A Kaltashov, Ning Huang, Anne B Mason.   

Abstract

The Fe(3+) binding protein human serum transferrin (hTF) is well known for its role in cellular iron delivery via the transferrin receptor (TFR). A new application is the use of hTF as a therapy and targeted drug delivery system for a number of diseases. Recently, production of hTF in plants has been reported; such systems provide a relatively inexpensive, animal-free (eliminating potential contamination by animal pathogens) method to produce large amounts of recombinant proteins for such biopharmaceutical applications. Specifically, the production of Optiferrin (hTF produced in rice, Oryza sativa, from InVitria) has been shown to yield large amounts of functional protein for use in culture medium for cellular iron delivery to promote growth. In the present work we describe further purification (by gel filtration) and characterization of hTF produced in rice (purified Optiferrin) to determine its suitability in biopharmaceutical applications. The spectral, mass spectrometric, urea gel and kinetic analysis shows that purified Optiferrin is similar to recombinant nonglycosylated N-His tagged hTF expressed by baby hamster kidney cells and/or serum derived glycosylated hTF. Additionally, in a competitive immunoassay, iron-loaded Optiferrin is equivalent to iron-loaded N-His hTF in its ability to bind to the soluble portion of the TFR immobilized in an assay plate. As an essential requirement for any functional hTF, both lobes of purified Optiferrin bind Fe(3+) tightly yet reversibly. Although previously shown to be capable of delivering Fe(3+) to cells, the kinetics of iron release from iron-loaded Optiferrin™/sTFR and iron-loaded N-His hTF/sTFR complexes differ somewhat. We conclude that the purified Optiferrin might be suitable for consideration in biopharmaceutical applications.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23010327      PMCID: PMC3483368          DOI: 10.1016/j.jinorgbio.2012.07.005

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  40 in total

Review 1.  A cloned gene for human transferrin.

Authors:  C L Hershberger; J L Larson; B Arnold; P R Rosteck; P Williams; B DeHoff; P Dunn; K L O'Neal; M W Riemen; P A Tice
Journal:  Ann N Y Acad Sci       Date:  1991-12-27       Impact factor: 5.691

Review 2.  Iron transport and storage proteins.

Authors:  P Aisen; I Listowsky
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

3.  Production of human serum transferrin in Escherichia coli.

Authors:  R A Ikeda; B H Bowman; F Yang; L K Lokey
Journal:  Gene       Date:  1992-08-15       Impact factor: 3.688

Review 4.  Kinetics of iron release from transferrin bound to the transferrin receptor at endosomal pH.

Authors:  Ashley N Steere; Shaina L Byrne; N Dennis Chasteen; Anne B Mason
Journal:  Biochim Biophys Acta       Date:  2011-06-15

5.  Expression of glycosylated and nonglycosylated human transferrin in mammalian cells. Characterization of the recombinant proteins with comparison to three commercially available transferrins.

Authors:  A B Mason; M K Miller; W D Funk; D K Banfield; K J Savage; R W Oliver; B N Green; R T MacGillivray; R C Woodworth
Journal:  Biochemistry       Date:  1993-05-25       Impact factor: 3.162

6.  Expression of the amino-terminal half-molecule of human serum transferrin in cultured cells and characterization of the recombinant protein.

Authors:  W D Funk; R T MacGillivray; A B Mason; S A Brown; R C Woodworth
Journal:  Biochemistry       Date:  1990-02-13       Impact factor: 3.162

7.  Production of N-terminal and C-terminal human serum transferrin in Escherichia coli.

Authors:  L M Steinlein; R A Ikeda
Journal:  Enzyme Microb Technol       Date:  1993-03       Impact factor: 3.493

8.  Optimized bacterial production of nonglycosylated human transferrin and its half-molecules.

Authors:  M H de Smit; P Hoefkens; G de Jong; J van Duin; P H van Knippenberg; H G van Eijk
Journal:  Int J Biochem Cell Biol       Date:  1995-08       Impact factor: 5.085

9.  How to measure and predict the molar absorption coefficient of a protein.

Authors:  C N Pace; F Vajdos; L Fee; G Grimsley; T Gray
Journal:  Protein Sci       Date:  1995-11       Impact factor: 6.725

10.  Efficient production and isolation of recombinant amino-terminal half-molecule of human serum transferrin from baby hamster kidney cells.

Authors:  A B Mason; W D Funk; R T MacGillivray; R C Woodworth
Journal:  Protein Expr Purif       Date:  1991 Apr-Jun       Impact factor: 1.650

View more
  5 in total

1.  Determination of supplier-to-supplier and lot-to-lot variability in glycation of recombinant human serum albumin expressed in Oryza sativa.

Authors:  Grant E Frahm; Daryl G S Smith; Anita Kane; Barry Lorbetskie; Terry D Cyr; Michel Girard; Michael J W Johnston
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

2.  Nanoparticle size and production efficiency are affected by the presence of fatty acids during albumin nanoparticle fabrication.

Authors:  Christian C Luebbert; Tessa M Clarke; Roberta Pointet; Grant E Frahm; Sharon Tam; Barry Lorbetskie; Simon Sauvé; Michael J W Johnston
Journal:  PLoS One       Date:  2017-12-27       Impact factor: 3.240

3.  Characterization of transferrin receptor-mediated endocytosis and cellular iron delivery of recombinant human serum transferrin from rice (Oryza sativa L.).

Authors:  Deshui Zhang; Hsin-Fang Lee; Steven C Pettit; Jennica L Zaro; Ning Huang; Wei-Chiang Shen
Journal:  BMC Biotechnol       Date:  2012-11-30       Impact factor: 2.563

4.  Human leukemia inhibitory factor produced by the ExpressTec method from rice (Oryza sativa L.) is active in human neural stem cells and mouse induced pluripotent stem cells.

Authors:  Randall Alfano; Bradford A Youngblood; Deshui Zhang; Ning Huang; Clinton C MacDonald
Journal:  Bioengineered       Date:  2014-04-28       Impact factor: 3.269

5.  Formulation and production of a blood-free and chemically defined virus production media for VERO cells.

Authors:  Randall Alfano; Atherly Pennybaker; Peter Halfmann; Claire Y-H Huang
Journal:  Biotechnol Bioeng       Date:  2020-08-01       Impact factor: 4.395

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.